FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Vincenzo Fragola

Research Profile

Disorders

Chemicals & Drugs

Procedures

Living Beings

HIV-1

Concepts & Ideas

Co-author Network

Publications

TOP 3
Silvia Baroncelli; Andrea Cara; Oscar Cirioni; Alessandra Fantauzzi; Rina Fidanza; Vincenzo Fragola; Daniela Francisci; Clementina M Galluzzo; Nicoletta Ladisa; Ivano Mezzaroma; Laura Sighinolfi; Angela Vivarelli; Vincenzo Vullo; Liliana E Weimer; Anna Degli Antoni; Lucia Palmisano
No evidence of autoimmune disorders in antiretroviral-experienced HIV-1-infected individuals after long-term treatment with raltegravir.
Liliana E Weimer; Rita Bellagamba; Raffaella Bucciardini; Stefania Cicalini; Anna Degli Antoni; Gabriella d'Ettorre; Marco Floridia; Vincenzo Fragola; Daniela Francisci; Andrea Giacometti; Giovanni Guaraldi; Nicoletta Ladisa; Raffaella Libertone; Paolo Emilio Manconi; Maria Stella Mura; Giustino Parruti; Roberta Preziosi; Loredana Sarmati; Laura Sighinolfi; Marcello Tavio; Gabriella Verucchi; Angela Vivarelli
Response to raltegravir-based salvage therapy in HIV-infected patients with hepatitis C virus or hepatitis B virus coinfection.
Raffaella Bucciardini; G Ceccarelli; O Cirioni; A Degli Antoni; Gabriella d'Ettorre; Marco Floridia; Vincenzo Fragola; Daniela Francisci; Clementina M Galluzzo; G Guaraldi; Nicoletta Ladisa; S Lucattini; P E Manconi; Giustino Parruti; Maria F Pirillo; R Preziosi; G Verucchi; V Vullo; Liliana E Weimer; Silvia Baroncelli; Rita Bellagamba
Virological failure at one year in triple-class experienced patients switching to raltegravir-based regimens is not predicted by baseline factors.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Vincenzo Fragola (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Silvia Baroncelli; Andrea Cara; Oscar Cirioni; Alessandra Fantauzzi; Rina Fidanza; Vincenzo Fragola; Daniela Francisci; Clementina M Galluzzo; Nicoletta Ladisa; Ivano Mezzaroma; Laura Sighinolfi; Angela Vivarelli; Vincenzo Vullo; Liliana E Weimer; Anna Degli Antoni; Lucia Palmisano
No evidence of autoimmune disorders in antiretroviral-experienced HIV-1-infected individuals after long-term treatment with raltegravir.
Antiviral therapy 2013;18(3):321-7.
2013: Liliana E Weimer; Rita Bellagamba; Raffaella Bucciardini; Stefania Cicalini; Anna Degli Antoni; Gabriella d'Ettorre; Marco Floridia; Vincenzo Fragola; Daniela Francisci; Andrea Giacometti; Giovanni Guaraldi; Nicoletta Ladisa; Raffaella Libertone; Paolo Emilio Manconi; Maria Stella Mura; Giustino Parruti; Roberta Preziosi; Loredana Sarmati; Laura Sighinolfi; Marcello Tavio; Gabriella Verucchi; Angela Vivarelli
Response to raltegravir-based salvage therapy in HIV-infected patients with hepatitis C virus or hepatitis B virus coinfection.
The Journal of antimicrobial chemotherapy 2013;68(1):193-9.
2012: Raffaella Bucciardini; G Ceccarelli; O Cirioni; A Degli Antoni; Gabriella d'Ettorre; Marco Floridia; Vincenzo Fragola; Daniela Francisci; Clementina M Galluzzo; G Guaraldi; Nicoletta Ladisa; S Lucattini; P E Manconi; Giustino Parruti; Maria F Pirillo; R Preziosi; G Verucchi; V Vullo; Liliana E Weimer; Silvia Baroncelli; Rita Bellagamba
Virological failure at one year in triple-class experienced patients switching to raltegravir-based regimens is not predicted by baseline factors.
International journal of STD & AIDS 2012;23(7):459-63.
2012: Silvia Baroncelli; Raffaella Bucciardini; Albertina Cavalli; Anna Degli Antoni; Vincenzo Fragola; Daniela Francisci; Clementina M Galluzzo; Nicoletta Ladisa; Alessandra Mercuri; Laura Monno; Maria F Pirillo; Anna Volpe; Liliana E Weimer; Marco Floridia
Evolution of proviral DNA HIV-1 tropism under selective pressure of maraviroc-based therapy.
The Journal of antimicrobial chemotherapy 2012;67(6):1479-85.
2010: Maria F Pirillo; Lucia Palmisano; Manuela Pellegrini; Clementina M Galluzzo; Liliana E Weimer; Raffaella Bucciardini; Vincenzo Fragola; Mauro Andreotti; Emilia Marchei; Simona Pichini; STEFANO VELLA; Marina Giuliano
Nonnucleoside reverse transcriptase inhibitor concentrations during treatment interruptions and the emergence of resistance: a substudy of the ISS-PART Trial.
AIDS research and human retroviruses 2010;26(5):541-5.
2009: Lucia Palmisano; Marina Giuliano; Clementina M Galluzzo; Roberta Amici; Mauro Andreotti; Liliana E Weimer; Maria F Pirillo; Vincenzo Fragola; Raffaella Bucciardini; STEFANO VELLA
The mutational archive in proviral DNA does not change during 24 months of continuous or intermittent highly active antiretroviral therapy.
HIV medicine 2009;10(8):477-81.
2008: Raffaella Bucciardini; Maurizio Massella; A Corpolongo; P Narciso; Vincenzo Fragola; Marco Mirra; S Donnini; O Viganò; S Costarelli; V Tozzi
T20QoL: an observational multicenter cohort study to evaluate the quality of life in HIV-patients treated with enfuvirtide (ENF, T-20) in combination with an optimized background therapy.
Biologics : targets & therapy 2008;2(3):577-81.
2007: Raffaella Bucciardini; Vincenzo Fragola; Maurizio Massella; Cosimo Polizzi; Marco Mirra; Ruth L Goodall; Dianne Carey; Fleur Hudson; Roberto Zajdenverg; Marco Floridia
Health-related quality of life outcomes in HIV-infected patients starting different combination regimens in a randomized multinational trial: the INITIO-QoL substudy.
AIDS research and human retroviruses 2007;23(10):1215-22.
2007: Lucia Palmisano; Marina Giuliano; Raffaella Bucciardini; Vincenzo Fragola; Mauro Andreotti; Clementina M Galluzzo; Maria F Pirillo; Liliana E Weimer; Romano Arcieri; Elena A P Germinario; Roberta Amici; Maria Grazia Mancini; Antonella d'Arminio Monforte; Francesco Castelli; Pietro Caramello; STEFANO VELLA
Determinants of virologic and immunologic outcomes in chronically HIV-infected subjects undergoing repeated treatment interruptions: the Istituto Superiore di Sanita-Pulsed Antiretroviral Therapy (ISS-PART) study.
Journal of acquired immune deficiency syndromes (1999) 2007;46(1):39-47.
2006: Raffaella Bucciardini; Rita Murri; M Guarinieri; Fabrizio Starace; M Martini; A Vatrella; Loredana Cafaro; Massimo Fantoni; R Grisetti; Antonella d'Arminio Monforte; Vincenzo Fragola; Romano Arcieri; Cosmo Del Borgo; Andrea Tramarin; Maurizio Massella; D Lorenzetti; STEFANO VELLA
ISSQoL: a new questionnaire for evaluating the quality of life of people living with HIV in the HAART era.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2006;15(3):377-90.
2005: Lucia Palmisano; Marina Giuliano; Emanuele Nicastri; Maria F Pirillo; Mauro Andreotti; Clementina M Galluzzo; Raffaella Bucciardini; Vincenzo Fragola; Massimo Andreoni; STEFANO VELLA
Residual viraemia in subjects with chronic HIV infection and viral load < 50 copies/ml: the impact of highly active antiretroviral therapy.
AIDS (London, England) 2005;19(16):1843-7.
2004: Marco Floridia; Raffaella Bucciardini; Vincenzo Fragola; Clementina M Galluzzo; Giacomo Giannini; Maria F Pirillo; Roberta Amici; Mauro Andreotti; D Ricciardulli; C Tomino; STEFANO VELLA
Risk factors and occurrence of rash in HIV-positive patients not receiving nonnucleoside reverse transcriptase inhibitor: data from a randomized study evaluating use of protease inhibitors in nucleoside-experienced patients with very low CD4 levels (<50 cells/microL).
HIV medicine 2004;5(1):1-10.
2002: Marco Floridia; Vincenzo Fragola; Clementina M Galluzzo; Giacomo Giannini; Maria F Pirillo; Mauro Andreotti; C Tomino; STEFANO VELLA
HIV-related morbidity and mortality in patients starting protease inhibitors in very advanced HIV disease (CD4 count of < 50 cells/microL): an analysis of 338 clinical events from a randomized clinical trial.
HIV medicine 2002;3(2):75-84.
2000: Marco Floridia; C Tomino; Raffaella Bucciardini; D Ricciardulli; Vincenzo Fragola; Maria F Pirillo; Roberta Amici; Giacomo Giannini; Clementina M Galluzzo; Mauro Andreotti; AC Seeber; Adriana Ammassari; A Cingolani; Adriano Lazzarin; G Scalise; Antonietta Cargnel; Fredy Suter; F Milazzo; G Pastore; Mauro Moroni; R Ciammarughi; R Pini; Giampiero Carosi; C D'Amato; L Contu; Ercole Concia; L Bonazzi; Fernando Aiuti; Gianmarco Vigevani; STEFANO VELLA
A randomized trial comparing the introduction of ritonavir or indinavir in 1251 nucleoside-experienced patients with advanced HIV infection.
AIDS research and human retroviruses 2000;16(17):1809-20.
2000: Raffaella Bucciardini; Albert W Wu; Marco Floridia; Vincenzo Fragola; D Ricciardulli; C Tomino; Liliana E Weimer; Maria F Pirillo; Marco Mirra; MAURO MARZI; Giacomo Giannini; Clementina M Galluzzo; Mauro Andreotti; Maurizio Massella; STEFANO VELLA
Quality of life outcomes of combination zidovudine- didanosine-nevirapine and zidovudine-didanosine for antiretroviral-naive advanced HIV-infected patients.
AIDS (London, England) 2000;14(16):2567-74.
2000: Marco Floridia; Maurizio Massella; Raffaella Bucciardini; C A Perucci; L Rossi; C Tomino; Vincenzo Fragola; D Ricciardulli; Clementina M Galluzzo; Giacomo Giannini; Maria F Pirillo; Mauro Andreotti; Marco Mirra; STEFANO VELLA
Hospitalizations and costs of treatment for protease inhibitor-based regimens in patients with very advanced HIV-infection (CD4 < 50/mm(3)).
HIV clinical trials 2000;1(2):9-16.
2000: STEFANO VELLA; Mariangela Galluzzo; Giacomo Giannini; Maria F Pirillo; Mauro Andreotti; C Tomino; Vincenzo Fragola; Raffaella Bucciardini; D Ricciardulli; Andrea Binelli; Liliana E Weimer; Marco Floridia
Plasma HIV-1 copy number and in vitro infectivity of plasma prior to and during combination antiretroviral treatment.
Antiviral research 2000;47(3):189-98.
1999: Janet Raboud; Sandra Rae; STEFANO VELLA; P Richard Harrigan; Raffaella Bucciardini; Vincenzo Fragola; D Ricciardulli; Julio S G Montaner
Meta-analysis of two randomized controlled trials comparing combined zidovudine and didanosine therapy with combined zidovudine, didanosine, and nevirapine therapy in patients with HIV. INCAS study team.
Journal of acquired immune deficiency syndromes (1999) 1999;22(3):260-6.
1999: Marco Floridia; Raffaella Bucciardini; D Ricciardulli; Vincenzo Fragola; Maria F Pirillo; Liliana E Weimer; C Tomino; Giacomo Giannini; Clementina M Galluzzo; Mauro Andreotti; Antonietta Cargnel; Francesco Alberici; B De Rienzo; Francesco Leoncini; F Fiaccadori; Daniela Francisci; W Grillone; L Ortona; M Piazza; A Scalzini; E Nigra; F Tumietto; STEFANO VELLA
A randomized, double-blind trial on the use of a triple combination including nevirapine, a nonnucleoside reverse transcriptase HIV inhibitor, in antiretroviral-naive patients with advanced disease.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1999;20(1):11-9.
1997: Marco Floridia; STEFANO VELLA; AC Seeber; C Tomino; Vincenzo Fragola; Liliana E Weimer; D Ricciardulli; F Milazzo; F M Gritti; Francesco Mazzotta; S Ranieri; F Chiodo; Mauro Moroni; Antonietta Cargnel; D Bassetti; V Giannini; L Cremoni; Ercole Concia; Alessandro Sinicco; Giampiero Carosi; Francesco Alberici; Ferdinando Dianzani
A randomized trial (ISS 902) of didanosine versus zidovudine in previously untreated patients with mildly symptomatic human immunodeficiency virus infection.
The Journal of infectious diseases 1997;175(2):255-64.
1997: STEFANO VELLA; Vincenzo Fragola; Lucia Palmisano
Recent advances in antiretroviral therapy of HIV infection.
Journal of biological regulators and homeostatic agents 1997;11(1-2):60-3.
1996: STEFANO VELLA; Marco Floridia; L G Dally; C Tomino; Vincenzo Fragola; Liliana E Weimer; Francesco Milazzo; Francesco Mazzotta; Mauro Moroni; G Pastore; G Scalise; Alessandro Sinicco; L Ortona; B De Rienzo; Ferdinando Dianzani
A randomized trial (ISS 901) of switching to didanosine versus continued zidovudine after the diagnosis of AIDS.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1996;12(5):462-9.
1994: STEFANO VELLA; M Giuliano; L G Dally; M G Agresti; C Tomino; Marco Floridia; Antonio Chiesi; Vincenzo Fragola; Mauro Moroni; M Piazza
Long-term follow-up of zidovudine therapy in asymptomatic HIV infection: results of a multicenter cohort study. The Italian Zidovudine Evaluation Group.
Journal of acquired immune deficiency syndromes 1994;7(1):31-8.